Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation
Authors:
- 1 August 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 104 (3) , 822-828
Abstract
Immunosuppression after organ transplantation is an acknowledged risk factor for skin cancer and lymphoma. We examined whether there was also an excess of leukemia in patients after transplantation and whether this might be related to a particular immunosuppressive treatment. Data from more than 170 000 patients indicated that organ transplantation is associated with a significantly increased risk for acute myeloid leukemia (AML). AML was more frequent after heart transplantation and lung transplantation than after kidney transplantation and was associated with immunosuppression by azathioprine, a thiopurine prodrug. Cellular resistance to thiopurines is associated with DNA mismatch repair (MMR) deficiency. We demonstrate that thiopurine treatment of human cells in vitro selects variants with defective MMR. Consistent with a similar selection in patient bone marrow, in 7 of 7 patients, transplant-related AML/myelodysplastic syndrome (MDS) exhibited the microsatellite instability (MSI) that is diagnostic for defective MMR. Because MSI occurs infrequently in de novo AML, we conclude that the selective proliferation of MMR-defective, azathioprine-resistant myeloid cells may contribute significantly to the development of AML/MDS in patients who have received organ transplants. Identifying azathioprine as a risk factor for AML/MDS suggests that discontinuing the use of azathioprine as an immunosuppressant might reduce the incidence of posttransplantation AML/MDS.Keywords
This publication has 43 references indexed in Scilit:
- Mechanisms of tolerance to DNA damaging therapeutic drugsCarcinogenesis, 2001
- Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemiaLeukemia, 2000
- Mammalian DNA Mismatch RepairAnnual Review of Genetics, 1999
- Cytotoxic Mechanism of 6-Thioguanine: hMutSα, the Human Mismatch Binding Heterodimer, Binds to DNA Containing S6-MethylthioguanineBiochemistry, 1997
- Role of Postreplicative DNA Mismatch Repair in the Cytotoxic Action of ThioguanineScience, 1996
- Cancer risk after renal transplantation in the nordic countries, 1964–1986International Journal of Cancer, 1995
- Incidence of non-hodgkin lymphoma in kidney and heart transplant recipientsThe Lancet, 1993
- Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesisNature, 1993
- Clues to the Pathogenesis of Familial Colorectal CancerScience, 1993
- The Purine Path to ChemotherapyScience, 1989